Medtronic Plc Return on Equity

Medtronic Plc (MDT) currently reports a ROE of 10.41%. That is below the Healthcare sector average of 11.15%. Use the charts on this page to explore Medtronic Plc's ROE history and peer comparisons.

Medtronic Plc's ROE of 10.41% is lower than the Healthcare sector average of 11.15%. That is roughly 6.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Medtronic Plc's current 10.41% should be judged against Healthcare norms (sector average: 11.15%) and against MDT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 10.41%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.15%. From there, open related valuation or income-statement pages for Medtronic Plc, and consider following MDT for alerts when major investors trade the stock.

Medtronic Plc is classified in the Healthcare sector. On ROE, it currently shows 10.41% versus a sector average near 11.15%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MDT with unrelated industries.